Synopsis
The brain is a unique organ with
respect to its non-uniformity of iron distribution, both regionally and
cellularly, and because of its iron accumulation pattern across the life span.
MRI allows to non-invasively map the iron content and therefore provides a
window into age and disease dependent mechanisms that are poorly understood. This
presentation will give an overview on the most relevant iron compounds in the brain,
their magnetic properties, and their cellular distribution. Additionally,
susceptibility related MRI methods for iron mapping will be presented and their
limitations will be discussed.Iron in the ageing brain
Iron is a ubiquitous trace element in the human
brain that plays an important role in numerous essential biological processes including
myelin production, oxygen transport, protein synthesis, mitochondrial
respiration, neurotransmitter synthesis, and neurotransmitter metabolism (1,2).
Iron mapping across the lifespan therefore provides a window to study
metabolism and composition of gray and white matter. While there is no iron in
the myelin itself, iron is heavily needed by the oligodendrocytes for myelin
synthesis (3). Consequently, iron deficiency in the fetus or during brain
maturation may have significant effects on brain development and functioning (4).
It is therefore not unexpected that the iron concentration scales with maturation
and shows the strongest increase in the first two decades of life (5).
Interestingly, iron accumulation shows a highly region specific level and dynamic
with highest concentrations found in deep gray matter (5,6). The reason for the
accumulation is not clear yet. It was observed that iron in deep gray matter
scales with cortical volume which suggest that deep gray matter could be the
storage place for metabolic relevant iron (7). On the other hand, iron
transport to the brain is considered mainly as a one way traffic which could support
accumulation. In the older brain, there is only little increase in iron
concentration. Inflammatory and neurodegenerative diseases may further
contribute to regional iron accumulation but their effect is rather small
compared to ageing effects (8,9).
Susceptibility of iron
MRI is an attractive tool to non-invasively map
the iron content and to learn more about iron accumulation in the human brain
because it is particularly sensitive for the iron induced susceptibility
changes. However, the relationship between total iron content and resulting
susceptibility is complex and typically counteracted by the diamagnetism of the
iron containing proteins or carriers and by other tissue component including
water (10). The magnetic properties of iron are largely determined by its
electrons. Closed subshells have zero magnetic moment, but iron atoms have an
unfilled d-shell and therefore a net magnetic moment. The orbital angular
momentum of an electron that takes part in bonding is usually quenched while
the other electrons still may have a magnetic moment. This moment lines up in
an external magnetic field and contributes to paramagnetic behavior which is
only slightly opposed by thermal agitation. The thermal agitation tends to
produce a random orientation of the magnetic moments and causes a temperature
dependent susceptibility (Curie paramagnetism) which shows an inverse
proportional relation of susceptibility and temperature. The effective magnetic
moment of the electrons can be approximated by the spin-only formula which
provides a moment of zero Bohr magnetons (BM) for oxyhemoglobin (spin S=0), a
moment of 4.90 BM for iron in deoxyhemoglobin
(spin S=4/2), and an effective moment of 3.87 BM for an iron atom in ferritin
(spin S=3/2). The resulting (molar) susceptibility is directly proportional to
the second power of the effective moment.
Iron compounds in the brain
Among all non-heme iron compounds in the brain,
ferritin and hemosiderin are the most relevant candidates. Ferritin is a
globular storage protein that keeps iron in a non-toxic and soluble state. In
the inner ferritin core with a diameter of about 5-7 mm, up to 4500 iron ions
can be stored as hydrated iron oxide (Fe3+) nanocrystal. The nature of this
crystal and its magnetic phases is still a matter of debate, but current models
consider the surface of the core as paramagnetic and the core as
anti-ferromagnetic (under the Neel temperature) with some superparamagnetic
behavior (11). For such a model, a linear relationship between total number of
iron atoms in the crystal and total susceptibility seems rather unlikely. Hemosiderin
is another larger iron compound. In contrast to ferritin, hemosiderin is an
amorphous substance with no fixed composition and contains conglomerates of
denatured proteins, lipids, and denatured ferritin particles. The iron within
hemosiderin was proposed to be Fe3+ oxide or hydroxide and is insoluble, but is
in equilibrium with the soluble ferritin pool. Hemosiderin is rarely found in
the healthy brain but especially abundant after hemorrhages and can accumulate
regionally in pathologies such as hemochromatosis, sickle cell anemia or
thalassemia. Other iron compounds in the brain that should be mentioned are
hemoglobin (oxygen transport in the blood), transferrin (iron transport), and
iron-sulfur proteins. Iron–sulfur proteins are a class of components that
assist in vital biochemical tasks in almost every living cell including
respiration, iron homeostasis and gene expression. The concentration of
transferrin and iron-sulfur proteins is usually below the detection limit of
MRI, but their dysregulation can cause regional accumulations of granular iron
deposits such as in Friedreich ataxia (12) which are detectable by MRI. From a
sub-cellular point of view, most of the iron is intracellular and located in
lysosomes and mitochondria. But highest iron concentrations can be found in
oligodendrocytes and their processes, in motor neurons, and in myelinated axons.
As already mentioned above, myelin itself contains no iron but iron can be
found close to the inner shell of the myelin sheets or at the surface where it
is associated with the processes of the oligodendrocytes (13)
Mapping iron in the brain
Among the various MRI techniques to assess iron
concentration, quantitative susceptibility mapping (QSM) and mapping of the R2*
relaxation rate have proven as the most relevant techniques. While they measure
different features of iron induced susceptibility changes, they both have shown
a linear dependency on iron concentration over the entire physiological range (14,15)
and can also be obtained from the same gradient echo sequence. While QSM
measures the total bulk susceptibility, R2* mapping is related to the
microscopic variation of susceptibility. However, QSM and R2* mapping suffer
from the same unresolved problem: The paramagnetism of the iron is counteracted
by the diamagnetism of the myelin and its orientational dependency which makes
iron mapping in white matter less reliable (16,17).
Acknowledgements
No acknowledgement found.References
1. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton
RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci
2004;5:863–873.
2. Fleming RE, Ponka P. Iron Overload in Human
Disease. N. Engl. J. Med. 2012;366:348–359.
3. Todorich
B, Pasquini JM, Garcia CI, Paez PM, Connor JR. Oligodendrocytes
and myelination: the role of iron. Glia. 2009;57:467-78.
4. Beard J. Iron deficiency alters brain development and
functioning. J
Nutr. 2003 May;133(5 Suppl 1):1468-72.
5. Hallgren B, Sourander P. The effect of age on the
non-haemin iron in the human brain. J. Neurochem. 1958;3:41–51.
6. Krebs N, Langkammer C, Goessler W, Ropele S,
Fazekas F, Yen K, Scheurer E. Assessment of trace elements in human brain using
inductively coupled plasma mass spectrometry. J. Trace Elem. Med. Biol. 2013.
7. Ropele S, Wattjes MP, Langkammer C et al. Multicenter
R2* mapping in the healthy brain. Magn Reson Med. 2014 Mar;71(3):1103-7.
8. Ropele S, Kilsdonk ID, Wattjes MP et al. Determinants
of iron accumulation in deep grey matter of multiple sclerosis patients. Mult Scler.
2014 Nov;20(13):1692-8.
9. Guan X, Xuan M, Gu Q, et al. Regionally progressive
accumulation of iron in Parkinson's disease as measured by quantitative
susceptibility mapping. NMR Biomed. 2016 Feb 8
10. Schenck JF. The role of magnetic susceptibility in
magnetic resonance imaging: MRI magnetic compatibility of the first and second
kinds. Med. Phys. 1996;23:815–850.
11. Brooks RA, Vymazal J, Goldfarb RB, Bulte JW, Aisen
P. Relaxometry and magnetometry of ferritin. Magn Reson Med 1998;40:227–35.
12. Martelli A, Puccio H. Dysregulation of cellular
iron metabolism in Friedreich ataxia: From primary iron-sulfur cluster deficit
to mitochondrial iron accumulation. Front. Pharmacol. 2014;5:1–11.
13. Meguro R, Asano Y, Odagiri S, Li C, Shoumura K.
Cellular and subcellular localizations of nonheme ferric and ferrous iron in
the rat brain: a light and electron microscopic study by the perfusion-Perls
and -Turnbull methods. Arch. Histol. Cytol. 2008;71:205–22.
14. Langkammer
C, Schweser F, Krebs N, et al. Quantitative susceptibility mapping (QSM) as a means
to measure brain iron? A post mortem validation study. Neuroimage
2012;62:1593–1599.
15. Langkammer C, Krebs N, Goessler W, Scheurer E,
Ebner F, Yen K, Fazekas F, Ropele S. Quantitative MR Imaging of Brain Iron?: A
Postmortem Validation Study. Radiology 2010;257:455–462.
16. Deistung A, Schäfer A, Schweser F,
Biedermann U, Turner R, Reichenbach JR. Toward in vivo
histology: a comparison of quantitative susceptibility mapping (QSM) with
magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength.
Neuroimage 2013;65:299–314.
17. Liu C, Li W, Johnson GA, Wu B. High-field (9.4 T)
MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility.
Neuroimage 2011;56:930–8.